BHVN: Biohaven Ltd Financial Statements

Balance sheet, income statement, and cash flow statements for Biohaven Ltd (BHVN).

OverviewDividends

$3.78B Market Cap.

As of 05/14/2025 5:00 PM ET (MRY) • Disclaimer

BHVN Market Cap. (MRY)


BHVN Shares Outstanding (MRY)


BHVN Assets (MRY)


Total Assets

$615.11M

Total Liabilities

$191.67M

Total Investments

$386.86M

BHVN Income (MRY)


Revenue

$0

Net Income

-$846.42M

Operating Expense

$885.11M

BHVN Cash Flow (MRY)


CF Operations

-$582.45M

CF Investing

-$244.97M

CF Financing

$677.77M

BHVN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$615,107,000 (19.85%)

$513,212,000 (-22.45%)

$661,783,000 (365.84%)

$142,061,000 (27.41%)

Assets Current

$538,472,000 (21.70%)

$442,446,000 (-24.62%)

$586,968,000 (519.01%)

$94,823,000 (5.65%)

Assets Non-Current

$76,635,000 (8.29%)

$70,766,000 (-5.41%)

$74,815,000 (58.38%)

$47,238,000 (117.26%)

Goodwill & Intangible Assets

$19,790,000 (0.00%)

$19,790,000 (0.00%)

$19,790,000 (0.00%)

$19,790,000 (0%)

Shareholders Equity

$423,436,000 (-1.06%)

$427,975,000 (-20.56%)

$538,771,000 (1453.06%)

$34,691,000 (106.73%)

Property Plant & Equipment Net

$17,320,000 (0.75%)

$17,191,000 (-1.83%)

$17,512,000 (34.60%)

$13,010,000 (71.66%)

Cash & Equivalents

$99,134,000 (-60.09%)

$248,402,000 (3.46%)

$240,089,000 (215.67%)

$76,057,000 (-7.82%)

Accumulated Other Comprehensive Income

$79,000 (221.54%)

-$65,000 (-122.89%)

$284,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$386,857,000 (189.96%)

$133,417,000 (-48.78%)

$260,464,000 (0%)

$0 (0%)

Investments Current

$386,857,000 (189.96%)

$133,417,000 (-48.78%)

$260,464,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$18,029,000 (15.74%)

$15,577,000 (-66.07%)

$45,915,000 (861.57%)

$4,775,000 (73.13%)

Accumulated Retained Earnings (Deficit)

-$1,345,714,000 (-169.52%)

-$499,292,000 (-447.93%)

-$91,124,000 (0%)

$0

Tax Assets

$0 (0%)

$13,252,000 (-71.28%)

$46,139,000 (365.53%)

$9,911,000 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$32,782,000 (18.91%)

$27,569,000 (-9.85%)

$30,581,000 (993.35%)

$2,797,000 (0%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$32,782,000 (18.91%)

$27,569,000 (-9.85%)

$30,581,000 (993.35%)

$2,797,000 (0%)

Total Liabilities

$191,671,000 (124.87%)

$85,237,000 (-30.71%)

$123,012,000 (159.68%)

$47,370,000 (36.44%)

Liabilities Current

$154,226,000 (178.27%)

$55,423,000 (-38.43%)

$90,021,000 (114.67%)

$41,935,000 (40.36%)

Liabilities Non-Current

$37,445,000 (25.60%)

$29,814,000 (-9.63%)

$32,991,000 (507.01%)

$5,435,000 (12.27%)

BHVN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$89,240,000 (42.17%)

$62,770,000 (-52.03%)

$130,860,000 (249.76%)

$37,414,000 (133.17%)

Research & Development Expense

$795,871,000 (113.21%)

$373,281,000 (-14.60%)

$437,072,000 (140.83%)

$181,486,000 (84.32%)

Operating Expenses

$885,111,000 (102.98%)

$436,051,000 (-23.22%)

$567,932,000 (159.45%)

$218,900,000 (91.17%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$735,000 (153.15%)

-$1,383,000 (-415.75%)

$438,000 (-67.94%)

$1,366,000 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$846,422,000 (-107.37%)

-$408,168,000 (28.43%)

-$570,279,000 (-166.74%)

-$213,796,000 (-80.16%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$846,422,000 (-107.37%)

-$408,168,000 (28.43%)

-$570,279,000 (-166.74%)

-$213,796,000 (-80.16%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$846,422,000 (-107.37%)

-$408,168,000 (28.43%)

-$570,279,000 (-166.74%)

-$213,796,000 (-80.16%)

Weighted Average Shares

$91,234,337 (28.14%)

$71,200,527 (59.14%)

$44,741,316 (13.63%)

$39,375,944 (0.00%)

Weighted Average Shares Diluted

$91,234,337 (28.14%)

$71,200,527 (59.14%)

$44,741,316 (13.63%)

$39,375,944 (0.00%)

Earning Before Interest & Taxes (EBIT)

-$845,687,000 (-106.49%)

-$409,551,000 (28.13%)

-$569,841,000 (-168.25%)

-$212,430,000 (-79.01%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$885,111,000 (-102.98%)

-$436,051,000 (23.22%)

-$567,932,000 (-159.45%)

-$218,900,000 (-91.17%)

BHVN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$244,974,000 (-288.69%)

$129,830,000 (142.60%)

-$304,790,000 (-32387.08%)

$944,000 (135.00%)

Net Cash Flow from Financing

$677,774,000 (219.84%)

$211,908,000 (-72.39%)

$767,597,000 (454.43%)

$138,447,000 (-9.06%)

Net Cash Flow from Operations

-$582,453,000 (-75.58%)

-$331,725,000 (-11.43%)

-$297,689,000 (-104.12%)

-$145,840,000 (-92.00%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$149,578,000 (-1671.86%)

$9,516,000 (-94.25%)

$165,547,000 (2667.02%)

-$6,449,000 (-108.76%)

Net Cash Flow - Business Acquisitions and Disposals

$391,000 (0%)

$0 (0%)

-$39,000,000 (-2172.26%)

$1,882,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$241,316,000 (-281.61%)

$132,878,000 (151.16%)

-$259,716,000 (0%)

$0 (0%)

Capital Expenditure

-$4,049,000 (-32.84%)

-$3,048,000 (49.82%)

-$6,074,000 (-547.55%)

-$938,000 (65.22%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$677,666,000 (173.34%)

$247,920,000 (-12.78%)

$284,255,000 (71863.29%)

$395,000 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$75,000 (115.09%)

-$497,000 (-215.85%)

$429,000 (0%)

$0 (0%)

Share Based Compensation

$71,963,000 (149.98%)

$28,787,000 (-85.13%)

$193,556,000 (194.88%)

$65,639,000 (122.51%)

Depreciation Amortization & Accretion

$7,855,000 (13.64%)

$6,912,000 (398.70%)

$1,386,000 (-0.50%)

$1,393,000 (1834.72%)

BHVN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-237.70% (-129.66%)

-103.50% (47.96%)

-198.90% (76.06%)

-830.70%

Return on Average Assets (ROAA)

-159.20% (-97.03%)

-80.80% (43.06%)

-141.90% (15.84%)

-168.60%

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-336.80% (-106.12%)

-163.40% (49.89%)

-326.10% (95.25%)

-6861.40%

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-4.03 (46.11%)

-7.47 (-585.86%)

-1.09

-

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

8.92 (11.17%)

8.02 (356.95%)

1.76

-

Debt to Equity Ratio (D/E)

0.45 (127.64%)

0.2 (-12.72%)

0.23 (-83.30%)

1.36 (-34.03%)

Earnings Per Share (EPS)

-9.28 (-61.95%)

-5.73 (55.06%)

-12.75 (-134.81%)

-5.43 (-80.40%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-6.43 (-36.73%)

-4.7 (30.74%)

-6.79 (-82.11%)

-3.73 (-86.59%)

Book Value Per Share (BVPS)

4.64 (-22.79%)

6.01 (-50.08%)

12.04 (1266.86%)

0.88 (106.81%)

Tangible Assets Book Value Per Share (TABVPS)

6.53 (-5.84%)

6.93 (-51.70%)

14.35 (362.13%)

3.1 (9.64%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (50.00%)

-8 (-300.00%)

-2

-

Enterprise Value Over EBITDA (EV/EBITDA)

-4.44 (46.68%)

-8.32 (-428.38%)

-1.57

-

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0

Current Ratio

3.49 (-56.27%)

7.98 (22.44%)

6.52 (188.37%)

2.26 (-24.73%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$586,502,000 (-75.19%)

-$334,773,000 (-10.21%)

-$303,763,000 (-106.95%)

-$146,778,000 (-86.61%)

Enterprise Value (EV)

$3,717,837,888 (10.96%)

$3,350,561,477 (274.19%)

$895,406,389

-

Earnings Before Tax (EBT)

-$845,687,000 (-106.49%)

-$409,551,000 (28.13%)

-$569,841,000 (-168.25%)

-$212,430,000 (-79.01%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$837,832,000 (-108.09%)

-$402,639,000 (29.17%)

-$568,455,000 (-169.36%)

-$211,037,000 (-77.95%)

Invested Capital

$374,739,000 (72.56%)

$217,166,000 (-36.59%)

$342,464,000 (4739.80%)

$7,076,000 (900.45%)

Working Capital

$384,246,000 (-0.72%)

$387,023,000 (-22.12%)

$496,947,000 (839.62%)

$52,888,000 (-11.68%)

Tangible Asset Value

$595,317,000 (20.65%)

$493,422,000 (-23.14%)

$641,993,000 (425.06%)

$122,271,000 (9.66%)

Market Capitalization

$3,776,915,888 (9.99%)

$3,434,000,477 (262.97%)

$946,074,389

-

Average Equity

$356,157,250 (-9.69%)

$394,373,500 (37.54%)

$286,731,000 (1014.12%)

$25,736,000

Average Assets

$531,700,750 (5.22%)

$505,301,250 (25.72%)

$401,922,000 (217.02%)

$126,780,000

Invested Capital Average

$251,081,250 (0.17%)

$250,647,250 (43.42%)

$174,770,000 (5545.03%)

$3,096,000

Shares

101,122,246 (26.03%)

80,233,656 (17.71%)

68,160,979 (90.27%)

35,822,511